Opportunity sponsored by: CTSI
PROPOSAL TITLE: Laser hair removal as a tre
The Accelerated Discharge Program team systemically collected data on common discharge barriers, developed expertise in addressing common discharge issues and discharge efficiencies, improved identification of patients likely to discharge and assisted with discharge tasks. Length of stay improved to 7.4 days in the intervention group. Through the Caring Wisely program, our interprofessional team seeks to develop a platform to communicate discharge barriers with other disciplines at the unit and the health system level through more Informatics and Apex build support. We ultimately aim to further increase the number of on-time discharges, improve estimated day of discharge (“EDD”) accuracy, reduce LOS, and support UCSF’s global capacity optimization efforts.
PROPOSAL TITLE: Reducing Hospital-Acquired Infections Through Creation of HAI Diagnostic Excellence at UCSF
PROJECT LEAD(S): Cass Sandoval, Adult Critical Care CNS; Amy Larsen, Adult Critical Care CNS; Lindsay Bolt, Adult Medical CNS
EXECUTIVE SPONSOR(S):
PROJECT LEAD(S):
-Chiara Corbetta-Rastelli, MD
-Kate Swanson, MD
EXECUTIVE SPONSOR(S):
-Juan Gonzalez, MD, MS, PhD, Division Chief, UCSF Maternal Fetal Medicine
-Melissa Rosenstein, MD, Medical Director for Quality and Patient Safety for UCSF OB
ABSTRACT:
PROPOSAL TITLE: Headache Evaluation and Diagnosis - with Generative Artificial INtelligence (HEAD-GAIN): Improving Access, Reducing Overutilization
PROJECT LEAD(S):
- Pierre Martin, MD, MEd
- Andrew Breithaupt, MD
EXECUTIVE SPONSOR(S):
- Maggie Waung, MD, PhD
ABSTRACT
PROJECT LEADS: Rebecca Carter, MD, Vidya Pai, MD, Clare Pearson, RN, CNL
EXECUTIVE SPONSORS: James Anderson, MD, Director of Neonatology, UCSF Benioff Children’s Hospital Oakland, Leslie Lusk, MD, Medical Director, ECMO Co-Medical Director, UCSF Benioff Children’s Hospital Oakland
[Created in error]
N/A (for 2026)
Plasma metagenomic sequencing (pmNGS) is an infectious disease diagnostic tool that detects microbial DNA from patient plasma1. Due to its unbiased nature, pmNGS can identify bacteria, fungi, parasites and DNA viruses, including those clinicians may have not considered in their differential diagnosis or that are difficult to identify via standard testing2. The diagnostic power of pmNGS can circumvent invasive and expensive diagnostic procedures3 and, potentially, shorten patient stays.
PROJECT LEAD(S): Jessica Reeves, PharmD